2021 Innovation Discovery Grants (IDG) Awarded

June 2, 2021

Thursday afternoon highlights also included the awarding of six Innovation Discovery Grants (IDG) to Mass General Brigham investigators working on gene and cell therapy (GCT) advancements. Each award winner will receive $100,000 toward ongoing development and future commercialization, based on the potential to improve health outcomes, meet articulated milestones, and attract follow-on investment as assessed…

Read More

2021 Innovation Discovery Grants Awarded

May 20, 2021

Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring. Read More: Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage, PhD, Brigham and Women’s Hospital…

Read More

Innovation Discovery Grants Awarded to Mass General Brigham Scientific Advancements Designed to Help Patients, Healthcare Delivery

January 6, 2021

Six disruptive scientific advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2020 round of awards, as the highly competitive IDG program exceeds $3.5 million in grants since inception. Each of the five potential patient health and healthcare delivery break-throughs for 2020 will receive $100,000 toward ongoing development and future…

Read More

The 2020 Disruptive Dozen

June 1, 2020

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies with the greatest potential to impact health care in the next year. The Disruptive Dozen results from interviews of…

Read More

Partners HealthCare Creates New Investment Funds to Accelerate Innovation in Medicine

October 21, 2019

$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. The funds will support ventures that develop new drugs and technologies based…

Read More
Staff Accelerator Program

New “Staff Accelerator” Program Emphasizes Life-Long Learning and Commercialization Excellence

February 21, 2019

Developing people and keeping pace with the rapidly changing world of healthcare innovation is at the heart of a new “Staff Accelerator” (SA) pilot program just launched at Partners HealthCare Innovation. Combining mentoring programs, developmental opportunities and career and skills development workshops, the SA program is just one part of an overall employee development strategy…

Read More

Pfizer Centers for Therapeutic Innovation: Fall 2018 Call-for-Proposals due November 2nd 2018

September 20, 2018

We are pleased to alert you to the call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. CTI supports translational programs in oncology, autoimmunity & inflammation, metabolic and rare diseases. Deadline to submit to Innovation:  Friday, November 2nd 2018 How to apply:  Please use the CTI Template to complete a non-confidential pre-proposal (max…

Read More

2019 Partners Innovation Discovery Grant Program: REQUEST FOR APPLICATIONS

July 30, 2018

We are delighted to announce the fourth round of the Innovation Discovery Grants Program (IDG). Partners HealthCare has renewed this grant program to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate the creation of new products from the innovations of all Partners employees and faculty. In 2019, the IDG program…

Read More

Innovators Honored at 2nd Annual Dinner

June 21, 2018

The Innovator’s Dinner was held Wednesday evening, April 25th as the concluding event of the 2018 World Medical Innovation Forum. This invitation-only dinner honored the 660 MGH, BWH, McLean and Spaulding principal investigators who submitted an invention disclosure during the calendar year 2017. Each investigator was recognized with a framed certificate and inclusion in the…

Read More

2018 World Medical Innovation Forum Recap

May 11, 2018

Thank you to our sell-out crowd of 1,700 registrants, the 169 speakers and our 19 sponsors. The 2018 Forum focused on the advancements and opportunities in Artificial Intelligence. Click here to read full recap!

Read More

Congratulations to the winners of the 2018 Innovation Discovery Grants

May 2, 2018

The Innovation Discovery Grants (IDG) program focuses on strategic scientific advancement with milestones geared towards mitigating risks for follow-on investment. While the program has existed for just four years, the thirty projects that have been awarded a combined $2 million, together have raised an additional $21 million to further their development. Roughly $12 million of…

Read More

Nuance and Partners HealthCare Collaborate to Accelerate Widespread Development, Deployment and Adoption of AI Applications for Diagnostic Imaging

March 7, 2018

At HIMSS 2018, Nuance Communications, Inc.(NASDAQ:NUAN), today announced the signing of a multi-year strategic agreement with Partners HealthCare. The two organizations will optimize the process for rapid development, validation and utilization of artificial intelligence (AI) for radiologists at the point of care, and Nuance intends to make the new algorithms available through the Nuance AI Marketplace for…

Read More

Innovation Symposium Series Displays Depth of PHS Faculty Team

January 8, 2018

Energetic audiences approaching 500 registered attendees gathered at the BWH and MGH campuses to attend the first three education sessions offered by Partners HealthCare Innovation. Featuring five unique sessions, the Innovation Symposium Series is focused on helping investigators navigate the commercial innovation lifecycle. Filling The Gap: Translating Your Research via Disease Foundation Support The September…

Read More

Registration now open for 2018 World Medical Innovation Forum: Save with Early Bird pricing!

November 7, 2017

The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of Artificial Intelligence. The Forum is a global gathering of more than 1,300 senior health care leaders in the heart of Boston. The event will bring together industry-leading CEOs, Partners’ HIT experts, investors and deal makers to share perspectives on how cognitive computation,…

Read More

IDG Supports Healthcare AI Applications

September 20, 2017

If you have an idea for improving healthcare in the field of artificial intelligence (AI), data science, cognitive computation, or machine learning that has the potential to turn into a commercial project, the organizers of the Innovation Discovery Grants Program (IDG) want to hear from you. Now in its third year, the IDG awards will…

Read More

Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Acting Oral Products

September 8, 2017

Lyndra, Inc. (Lyndra) announced today a partnership with Allergan plc to develop orally administered ultra-long-acting (once-weekly) products for the treatment of Alzheimer’s disease. The basis of the collaboration between the Boston-based startup and Allergan is Lyndra’s innovative sustained-release technology, which has the potential to transform drugs typically dosed daily to once-weekly oral dosing.

Read More

$500,000 Partners Innovation Discovery Grant Program: REQUEST FOR APPLICATIONS

August 9, 2017

PARTNERS INNOVATION DEVELOPMENT GRANTS PROGRAM Program Guidelines – 2018 Program Cycle BACKGROUND AND PURPOSE The Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and to increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate commercialization…

Read More

Sebacia Announces $36 Million Equity and Debt Financing to Advance Breakthrough In-Office Procedure for Acne

August 4, 2017

Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund. New investors accounted for approximately 60 percent of the round and include Salem…

Read More